These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9876570)

  • 1. Bioabsorbable polymers for implantable therapeutic systems.
    Sinha VR; Khosla L
    Drug Dev Ind Pharm; 1998 Dec; 24(12):1129-38. PubMed ID: 9876570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease.
    Yue IC; Poff J; Cortés ME; Sinisterra RD; Faris CB; Hildgen P; Langer R; Shastri VP
    Biomaterials; 2004 Aug; 25(17):3743-50. PubMed ID: 15020150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of drug type on the degradation rate of PLGA matrices.
    Siegel SJ; Kahn JB; Metzger K; Winey KI; Werner K; Dan N
    Eur J Pharm Biopharm; 2006 Nov; 64(3):287-93. PubMed ID: 16949804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local delivery of doxorubicin for malignant glioma by a biodegradable PLGA polymer sheet.
    Manome Y; Kobayashi T; Mori M; Suzuki R; Funamizu N; Akiyama N; Inoue S; Tabata Y; Watanabe M
    Anticancer Res; 2006; 26(5A):3317-26. PubMed ID: 17094447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
    Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
    Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable polymers in controlled drug delivery.
    Heller J
    Crit Rev Ther Drug Carrier Syst; 1984; 1(1):39-90. PubMed ID: 6400195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Size and temperature effects on poly(lactic-co-glycolic acid) degradation and microreservoir device performance.
    Grayson AC; Cima MJ; Langer R
    Biomaterials; 2005 May; 26(14):2137-45. PubMed ID: 15576189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
    Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
    J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable drug delivery systems based on aliphatic polyesters: application to contraceptives and narcotic antagonists.
    Pitt CG; Marks TA; Schindler A
    NIDA Res Monogr; 1981; 28():232-53. PubMed ID: 6791007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lactide/glycolide monomers on release behaviors of gentamicin sulfate-loaded PLGA discs.
    Yoo JY; Kim JM; Khang G; Kim MS; Cho SH; Lee HB; Kim YS
    Int J Pharm; 2004 May; 276(1-2):1-9. PubMed ID: 15113609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant.
    Koort JK; Makinen TJ; Suokas E; Veiranto M; Jalava J; Tormala P; Aro HT
    Acta Orthop; 2008 Apr; 79(2):295-301. PubMed ID: 18484258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation behaviour in vitro for poly(D,L-lactide-co-glycolide) as drug carrier.
    Lee JS; Chae GS; Kim MS; Cho SH; Lee HB; Khang G
    Biomed Mater Eng; 2004; 14(2):185-92. PubMed ID: 15156109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraceptive devices: subcutaneous delivery systems.
    Benagiano G; Gabelnick H; Farris M
    Expert Rev Med Devices; 2008 Sep; 5(5):623-37. PubMed ID: 18803473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mathematical model for interpreting in vitro rhGH release from laminar implants.
    Santoveña A; García JT; Oliva A; Llabrés M; Fariña JB
    Int J Pharm; 2006 Feb; 309(1-2):38-43. PubMed ID: 16376037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.
    Khan A; Sommer W; Fuxe K; Akhtar S
    J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres.
    Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
    Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled degradation of multilayered poly(lactide-co-glycolide) films using electron beam irradiation.
    Chia NK; Venkatraman SS; Boey FY; Cadart S; Loo JS
    J Biomed Mater Res A; 2008 Mar; 84(4):980-7. PubMed ID: 17647238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
    Liu SQ; Tong YW; Yang YY
    Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabrication of multi-layered biodegradable drug delivery device based on micro-structuring of PLGA polymers.
    Ryu WH; Vyakarnam M; Greco RS; Prinz FB; Fasching RJ
    Biomed Microdevices; 2007 Dec; 9(6):845-53. PubMed ID: 17577671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.